CareDx CDNA recently announced clinical validation data supporting AlloHeme, its next-generation, blood-based monitoring test designed to predict relapses in patients with acute myeloid leukemia (AML) ...

In a cohort of US veterans with prostate cancer who were on active surveillance, negative multiparametric MRI had a 75% negative predictive value for ruling out disease of grade group 2 or higher at ...

Clinicians often face uncertainty about whether they can rely on a negative chest x-ray (CXR) to rule out pneumonia in a child, even when other clinical signs and symptoms may have raised that concern ...